BioSpace News Archive

Alvotech announced that it will release financial results for full year 2022, after U.S. markets close on Wednesday, March 1, 2023.

GC Biopharma Corp. (006280.KS), a leading provider of biopharmaceutical products in South Korea, announced today that it has signed an Asset Purchase Agreement with Catalyst Biosciences (NASDAQ : CBIO) to acquire 3 programs related to the orphan hematology disorders.

RemeGen Co., Ltd. continues to strengthen its social responsibility and rare disease advocacy in unison with Rare Disease Day 2023’s message of continuing to increase visibility and generate change for the millions of people globally living with a rare disease, their families and carers.

Pulnovo Medical Limited, a globally recognized OTM platform, announced positive one-year results from the Pulmonary Artery Denervation (PADN)-CFDA pivotal study at the industry’s most leading American Cardiovascular Research Technologies conference (CRT 2023).

Thrive Bioscience Inc., an innovative provider of automated live cell imaging instruments and software, debuts a new integrated suite of unique and exciting capabilities, including Release 4.0 of its CellAssist software, that significantly advances the field of live cell imaging.

Shanghai Junshi Biosciences Co., Ltd announced the successful completion of two randomized, double-blind, placebo-controlled, multi-center phase III clinical studies evaluating the company’s product ongericimab for the treatment of primary hypercholesterolemia and mixed hyperlipidemia, and both studies have met their primary endpoints.